about
Clinical significance of hepatitis B e antigen level measurement during long-term lamivudine therapy in chronic hepatitis B patients with e antigen positive.Prognostic impact of telomere maintenance gene polymorphisms on hepatocellular carcinoma patients with chronic hepatitis B.Poor prognostic factors in patients who underwent surgery for acute non-occlusive ischemic colitis.Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis BTristetraprolin regulates expression of VEGF and tumorigenesis in human colon cancer.Tenofovir-based rescue therapy for chronic hepatitis B patients who had failed treatment with lamivudine, adefovir, and entecavir.Efficacy and safety of tenofovir in nucleos(t)ide-naïve patients with genotype C chronic hepatitis B in real-life practice.Efficacy of Tenofovir-based Rescue Therapy in Lamivudine-resistant Chronic Hepatitis B Patients With Failure of Lamivudine and Adefovir Combination.Colonic mucormycosis presented with ischemic colitis in a liver transplant recipientErratum to: Poor prognostic factors in patients who underwent surgery for acute non-occlusive ischemic colitisA gastrointestinal stromal tumor of the duodenum masquerading as a pancreatic head tumor.The expression kinetics of CD137 in chronic hepatitis C patients treated with pegylated-interferon and ribavirin.Endoscopic enucleation for gastric subepithelial tumors originating in the muscularis propria layer.The level of HBV DNA at month 12 is an important predictor of virological breakthrough during adefovir monotherapy in chronic hepatitis B patients with lamivudine resistance.MONW phenotype is associated with advanced colorectal adenoma in Korean men.HBV DNA level at 24 weeks is the best predictor of virological response to adefovir add-on therapy in patients with lamivudine resistance.Clinical course of patients with insufficient viral suppression during entecavir therapy in genotype C chronic hepatitis B.Clinical usefulness of sequential hepatitis B virus DNA measurement (the roadmap concept) during adefovir treatment in lamivudine-resistant patients.[The outcome of endoscopic treatment in bile duct injury after cholecystectomy].Tristetraprolin downregulates the expression of both VEGF and COX-2 in human colon cancer.Reply: To PMID 23907815.The effectiveness of endoscopic submucosal resection with a ligation device for small rectal carcinoid tumors: focused on previously biopsied tumors.Polymorphisms of DNA repair genes in Korean hepatocellular carcinoma patients with chronic hepatitis B: possible implications on survival.Mitotic checkpoint gene MAD1 in hepatocellular carcinoma is associated with tumor recurrence after surgical resection.Successful outcomes of endoscopic resection for gastric adenomas and early cancers located on the pyloric ring (with video).[Clinical outcomes of lamivudine therapy in HBeAg positive chronic hepatitis B with minimally elevated ALT].[Clinical features of fulminant hepatic failure in a tertiary hospital with a liver transplant center in Korea].[Hemobilia from pancreatic arteriovenous malformation: successful treatment with transportal coil embolization of draining veins]Somatic Mutation of ARHI Gene in Hepatocellular Carcinomas
P50
Q34017787-524B60E5-8A8F-477D-B42D-EA266D2BB1FEQ34888659-7A635959-2841-461F-A0DD-3219D7A43435Q35204272-0137D332-1706-467E-9949-067E06C8AD44Q36779207-A6D7DECD-43FD-4585-9B6F-7CA720F0EB35Q39810006-0FEA77A3-2995-4819-934D-5DF671EC8345Q40940597-78C9EE82-3A4D-4493-978E-9C1E4A89118AQ41367567-73FFBE28-A463-432D-B738-745AF6078A08Q41752080-492DE08E-93A0-4993-B1A1-095A4F8C6763Q41856407-D71DC5FA-6F8F-4150-9C7B-1C5B21D2890EQ42745183-E583CF6E-B11F-4F5F-8542-50B1F6244336Q42911536-AA0ABA20-E0E1-4D35-8D70-CB9DB9C308CDQ42978363-C0457E0A-0F3D-40A8-AA50-065313C7D5B8Q43506099-2A634FB0-CC0D-47BB-8D74-E185828ECFB9Q44519264-5063EEED-67A9-4B38-9813-DC08D5FB7CDCQ44525622-3E5A231A-EF34-4B5B-A0A1-71F6ECE74794Q44790347-BDAD8A4A-D4F4-49E4-9218-933798407F8CQ44933951-387F43D2-6934-4AD5-9884-23AD10421D5BQ45384667-302C1619-67FE-4CFC-B2AE-8DF3F88182EDQ50151463-537B48FB-C1B1-4DF9-A99A-177B96B4E8D0Q53283299-E94A91C2-3028-4127-9AD9-5EC92941CDACQ53285466-0A9FEF01-C80B-4324-B8C1-EFAA9FD50398Q53287602-D1B5C2CC-A4ED-4F38-B026-0FF30449DB42Q53373541-0E6B9BE7-9DB1-46B6-AB56-7CA9FD6E2B07Q53476339-89F94B13-E4DF-4B75-81E8-0E11A30C50B5Q53478459-96A79A4E-C5A6-4C0C-9C11-75B55E246E48Q53567774-EC6CFED3-8149-4C65-ADF8-BA42BCCF0BE6Q53600987-5C1F1CE1-DE75-4DBC-BC5E-991DDB1E0E00Q64045164-5D3DE1FA-3B13-4549-920B-2A31F6DAB3FCQ85529587-BAA16BCC-ABFF-446D-89D3-334ACE2CC071
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Seok Won Jung
@ast
Seok Won Jung
@en
Seok Won Jung
@es
Seok Won Jung
@nl
Seok Won Jung
@sl
type
label
Seok Won Jung
@ast
Seok Won Jung
@en
Seok Won Jung
@es
Seok Won Jung
@nl
Seok Won Jung
@sl
prefLabel
Seok Won Jung
@ast
Seok Won Jung
@en
Seok Won Jung
@es
Seok Won Jung
@nl
Seok Won Jung
@sl
P106
P31
P496
0000-0001-7001-0341